StockData
Cue Biopharma, Inc. logo

Cue Biopharma, Inc. (CUE) stock

CUENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/30
$2.83−11.27 (-79.93%)

Close on Nov 17, 2026Market cap $20.56MP/E –Yield –

Cue Biopharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cue Biopharma's total debt was $100.00K at Mar 31, 2025. For fiscal 2024 it was $37.00K, down 99.6% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$37.00K-99.6%
FY2023Dec 31, 2023$8.24M-18.5%
FY2022Dec 31, 2022$10.11M–
FY2021Dec 31, 2021$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025$100.00K-98.6%
Q4 FY2024Dec 31, 2024$37.00K-99.6%
Q3 FY2024Sep 30, 2024$5.33M-41.8%
Q2 FY2024Jun 30, 2024$6.29M-37.9%
Q1 FY2024Mar 31, 2024$7.28M-27.7%
Q4 FY2023Dec 31, 2023$8.24M-18.5%
Q3 FY2023Sep 30, 2023$9.16M-8.7%
Q2 FY2023Jun 30, 2023$10.12M+2.1%
Q1 FY2023Mar 31, 2023$10.08M+2.2%
Q4 FY2022Dec 31, 2022$10.11M–
Q3 FY2022Sep 30, 2022$10.03M–
Q2 FY2022Jun 30, 2022$9.91M–
Q1 FY2022Mar 31, 2022$9.86M–
Q4 FY2021Dec 31, 2021$0–

More Cue Biopharma figures

See a number that looks wrong?